Tumour necrosis factor receptor 1 inhibition and cardiovascular disease: a cis-Mendelian randomization study
14 April 2023 (18:18 - 18:30)
Organised by:
About the speaker
University of Oxford and Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Doctor H. MacLachlan (London, GB)
Doctor A. Alkandari (Kuwait City, KW)
Doctor M. Shah (London, GB)
Access the full session
The Event
ESC Preventive Cardiology 2023
14 April 2023
18:18 CET
You may be interested in
Congress Session
Congress Session
Congress Session
